TNXP
Tonix Pharmaceuticals Holding Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$13.24
-0.17 ▼ -1.27%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$13.21
-0.03 ▼ -0.23%
| Index | RUT | P/E | - | EPS (ttm) | -14.26 | Insider Own | 0.05% | Shs Outstand | 0.01B | Perf Week | -1.56% |
| Market Cap | 0.18B | Forward P/E | - | EPS next Y | 60.37% | Insider Trans | - | Shs Float | 0.01B | Perf Month | -16.52% |
| Enterprise Value | -0.03B | PEG | - | EPS next Q | -2.58 | Inst Own | 29.4% | Short Float | 16.46% | Perf Quarter | -32.96% |
| Income | -0.12B | P/S | 13.54 | EPS this Y | 46.49% | Inst Trans | 12.24% | Short Ratio | 5.26 | Perf Half Y | -57.58% |
| Sales | 0.01B | P/B | 0.69 | EPS next 5Y | 47.57% | ROA | -56.37% | Short Interest | 2.10M | Perf YTD | -15.24% |
| Book/sh | 19.17 | P/C | 0.85 | EPS past 3/5Y | 93.94% 86.72% | ROE | -64.48% | 52W High | -81.08% ($69.97) | Perf Year | -2.93% |
| Cash/sh | 15.49 | P/FCF | - | Sales past 3/5Y | - | ROIC | -50.35% | 52W Low | 3.44% ($12.80) | Perf 3Y | -99.91% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 81.36% | Gross Margin | 34.65% | Volatility(W/M) | 6.07% 5.24% | Perf 5Y | -100% |
| Dividend TTM | - | EV/Sales | -2.2 | Sales Y/Y TTM | 29.85% | Oper. Margin | -959.05% | ATR (14) | 0.83 | Perf 10Y | -100% |
| Dividend Ex-Date | - | Quick Ratio | 7.23 | EPS Q/Q | 99.59% | Profit Margin | -946.22% | RSI (14) | 34.64 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.42 | Sales Q/Q | 108.75% | SMA20 | -6.87% ($14.22) | Beta | 1.82 | Target Price | $66.33 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 3000000 | SMA50 | -15.38% ($15.65) | Rel Volume | 1.06 | Prev Close | $13.41 |
| Employees | 142 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -24.76% 81.68% | SMA200 | -48.74% ($25.83) | Avg Volume(3M) | 0.40M | Price | $13.24 |
| IPO | 2012/2/3 | Option/Short | Yes/Yes | Trades | 4890 | Volume | 423,645 | Change | -1.27% |
뉴스 로딩 중...